Eliquis vs. Xarelto: Which Blood Thinner Do Cardiologists Actually Choose?
Cardiologists overwhelmingly choose Eliquis. That is not speculation or marketing — it is what the prescription data, the clinical evidence, and the...
New Crohn’s Drug Gets Fast-Track Approval — Here’s What It Does
A drug called ontunisertib, developed by Agomab Therapeutics, has received FDA fast-track designation for fibrostenosing Crohn's disease — making it the...
Why Doctors Are Now Concerned About Long-Term Antacid Use
Doctors are raising alarms about long-term antacid use because a growing body of evidence links proton pump inhibitors — medications like omeprazole,...
The IBS Drug That’s Finally Working When Everything Else Failed
The drug is called Ibsrela (tenapanor), and for a growing number of people with IBS-C who cycled through Linzess, Amitiza, Trulance, and even the...
Reglan Side Effect Can Be Permanent — Millions Were Never Warned
Yes, Reglan — one of the most commonly prescribed anti-nausea and heartburn drugs in America — can cause a permanent neurological condition called tardive...
This Anti-Nausea Drug Is Being Used for Something Completely Unexpected
Tradipitant, an anti-nausea drug that earned FDA approval in late December 2025 as the first new prescription motion sickness treatment in over four...
What Happens to Your Stomach When You Stop Taking Acid Blockers
When you stop taking acid blockers — specifically proton pump inhibitors like omeprazole, pantoprazole, or esomeprazole — your stomach fights back by...
Pepcid vs. Prilosec: A Gastroenterologist Explains Which Actually Works
Prilosec works better than Pepcid for most people with frequent heartburn — and the clinical data is not particularly close.
The Gut Drug That’s Behind an Epidemic of Bone Fractures
The gut drug behind a growing epidemic of bone fractures is not some obscure experimental medication.
Prilosec and Nexium Are Destroying Your Magnesium Levels — Doctors Warn
Yes, the warning is real — and it has been on the books since 2011. The FDA issued a formal Drug Safety Communication on March 2, 2011, confirming that...